THE TAPE
CAH · Drug Wholesalers · $66.0B

Cardinal Health, Inc.

$283.85▲ +0.98%
Last close
Relative strength
88RS
of 99, against every stock▲ +2 on the month
Powering up
Unconfirmed
+41.8%
six months against the S&P 500
52-week range
−0.9%
from the high
$180.45$286.29
Setup
On no screen
No base, flag or squeeze in place tonight. What is and is not there
No report date on the calendar.
No US GAAP filings to read.
Why it is on no screen

CAH is off the screens on one check: a base has formed.

A base has formedNo pause of 3 weeks or more inside the last 24 weeks.
Long enough to countNeeds a base first.
Shallow enoughNeeds a base first.
Close to its pivotNeeds a base first.
Relative strengthRS 88 against 70 needed.

Measured against the base-and-breakout thresholds. The other screens use their own numbers, so a name can miss here and still be a fair-looking chart.

Draw
9-dayabout two weeks21-dayabout a month50-dayabout a quarter200-dayabout a year
Support and resistance
Support below
$259.12
-8.7% · tested 3× · last 11 sessions ago
Resistance above
None within the last 120 sessions

Prices this stock has turned at three or more times in the last 120 sessions, with how many times. Where buyers and sellers showed up before, not a forecast, an entry or a stop.

The read

Cardinal Health, Inc. is not on any of the screens right now. Its relative strength rating is 88, and it sits in Drug Wholesalers.

Against its industry
UnconfirmedNone of the patterns above holds.
One month against the S&P 500
+15.2%
Three months against the S&P 500
+25.3%
Six months against the S&P 500
+41.8%

Its industry has too few members to make an index of, so it is read against the S&P 500 and can only be turning, caution or unconfirmed.

Peers
Same industry
Same theme
No themes — common and fine.
Catalyst roadmap
49
days
Ex-dividend in 49 days
Jan 4, 2027
  1. Ex-dividendconfirmedin 49d
    Ex-dividend date
    Jan 4, 2027
How it moves on earnings

On average 6.2% either way across its last 8 reports.

Checking your subscription…

Close before the report day to close after it, so it holds whether the company reported before the open or after the close.

The business

No figures in US GAAP filings for this company. Most foreign listings report under international standards, which this does not read.

Tracked funds

Held by 2 of 46 tracked funds at the end of Q3 2026.

Last quarter: 1 bought new, 1 added.

Checking your subscription…

From 13F filings, which show long stock only and arrive up to 45 days after the quarter. The broad quant funds are left out.

Flagged by the market sweep
Reported resultsFiling · 2026-11-11
2.02
No measurable effect: stocks behave like random ones over the next three sessions (2,340 cases over 54 nights).
Closed above its 20- and 50-day on heavy volumeTape · 2026-11-06
above 20d & 50d on 1.7x volume at 267.82
Mixed: stocks have outrun random stocks by 0.2% over three sessions, not consistently enough to call (1,668 cases over 60 nights). Against their own sector they have lagged by 0.7%.
Earnings comingEvent · 2026-11-04
reports 2026-11-05 bmo
No measurable effect: stocks behave like random ones over the next three sessions (2,970 cases over 40 nights).
Several insiders soldInsider · 2026-09-19
7 insiders sold $59,552,442
No measurable effect: stocks behave like random ones over the next three sessions (653 cases over 60 nights).
Unusual volumeTape · 2026-09-19
5.2 sigma
After this signal, stocks have lagged random stocks by 0.1% over the next three sessions (6,474 cases over 55 nights). Against their own sector they have lagged by 0.4%.
Several insiders soldInsider · 2026-09-18
7 insiders sold $59,552,442
No measurable effect: stocks behave like random ones over the next three sessions (653 cases over 60 nights).
Several insiders soldInsider · 2026-09-17
7 insiders sold $59,552,442
No measurable effect: stocks behave like random ones over the next three sessions (653 cases over 60 nights).
Several insiders soldInsider · 2026-09-16
7 insiders sold $59,552,442
No measurable effect: stocks behave like random ones over the next three sessions (653 cases over 60 nights).

From a separate overnight market sweep, not from the screens on this site. What it flagged, not what it means. The track record is the sweep's own, measured against random stocks over the last 90 days.

In the news
Insiders
Bought on the open market
0
Sold on the open market
31
$59,552,442 total

Sold: Scherer Mary C., Hollar Jason M., Mason Stephen M, WEITZMAN DEBORAH, Alt Aaron E, Mayer Jessica L, Greene Michelle D..

Not counted above: 24 filings for awards, option exercises, gifts or shares withheld to pay tax. Those follow a vesting schedule nobody chose the timing of, and counting them as selling is how that number gets misread.

Most recent filings
2026-08-19 Scherer Mary C. · Chief Accounting Officersell100$23,740
2026-08-19 Scherer Mary C. · Chief Accounting Officersell2,202$522,733
2026-08-19 Hollar Jason M. · Chief Executive Officersell6,206$1,447,363
2026-08-19 Hollar Jason M. · Chief Executive Officersell3,457$809,941
2026-08-19 Hollar Jason M. · Chief Executive Officersell5,704$1,342,379
2026-08-19 Hollar Jason M. · Chief Executive Officersell6,731$1,591,612
2026-08-19 Hollar Jason M. · Chief Executive Officersell16,187$3,840,042
2026-08-19 Hollar Jason M. · Chief Executive Officersell6,244$1,485,323

From SEC Form 4, filed within two business days of the trade. What was filed, not what it means.

What analysts expect
Strong buy3
Buy11
Hold3
Sell0
Strong sell0

These are analysts’ estimates, not ours, and not a projection this site endorses. They are published here because what the sell side expects is itself a fact about the market.

Checking your subscription…

Gamma concentration

No option open interest for this company. Most listed names have no options at all, and we only read chains for names carrying a dated event, so this is a normal reading rather than a fault.

X-ray

No completed base to compare this one with yet.

A screening and market-analytics tool. Not investment advice. We are not a registered investment adviser. A stock on a screen matches a shape; that is not a prediction. Prices are end-of-day, not live.

What that means, in full
Cardinal Health, Inc. (CAH) — The Tape